Drug Manufacturers - General Industry

Drug Manufacturers - General industry analysis: EL7 Score and the best stocks ranked by value, profitability, and momentum.

EL7 Score

81Strong

22 of 151

P/E 23.0 vs period average 22.6 Near its historical average

Total stocks19

Total Market Cap$4.2T

Median P/E23.0x

Median Net Margin13.0%

Value

Growth

Best Stocks in Drug Manufacturers - General

Ranked among 17 stocks with a market cap above $500M. Smaller companies are excluded from the ranking.

Rank	Company	Price	Change	P/E	Fwd P/E	Value	Growth	Quality	Safety	Capital Return	EL7 Score
1/17	LLYEli Lilly and	$1115.25	-0.7%	37.4	28.8	10	100	95	71	30	83
2/17	NVONovo Nordisk A/S	$43.07	-2.1%	10.8	—	66	29	81	75	74	70
3/17	BMYBristol-Myers Squibb	$63.64	-0.2%	14.0	10.5	71	21	46	29	85	68
4/17	ABBVAbbVie	$257.06	+0.8%	72.6	16.9	18	68	79	14	39	60
5/17	GSKGSK	$48.13	+0.0%	13.7	—	79	43	48	40	26	52
6/17	MRKMerck	$143.94	-0.5%	114.2	16.5	26	38	35	30	46	48
7/17	OGNOrganon	$13.64	+0.1%	17.5	3.8	92	8	33	2	56	46
8/17	NVSNovartis	$137.16	-0.2%	20.6	15.0	52	32	76	41	57	44
9/17	AZNAstraZeneca	$160.17	+0.3%	23.8	14.7	42	81	57	49	54	43
10/17	PFEPfizer	$27.72	+0.3%	36.5	9.9	63	6	37	17	52	38

Page 1 of 2

Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.

ETFs with exposure to this sector

Funds that track the sector and each fund's exposure to it.

Fund	Exposure	Assets	Expense	Holdings
IBBiShares Biotechnology ETF	100.0%	$10B	0.44%	244
VHTVanguard Health Care ETF	100.0%	$21B	0.09%	411
IHIiShares U.S. Medical Devices ETF	99.7%	$3B	0.37%	46
XLVState Street Health Care Select Sector SPDR ETF	99.2%	$43B	0.08%	60

The percentage is the sector's share of the fund's assets, per the latest available data.